CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $173,000 | -86.0% | 345,067 | -34.8% | 0.00% | -88.5% |
| Q1 2018 | $1,232,000 | -5.2% | 528,874 | +19.3% | 0.03% | -7.1% |
| Q4 2017 | $1,299,000 | +964.8% | 443,455 | +937.7% | 0.03% | +1300.0% |
| Q3 2017 | $122,000 | -91.7% | 42,735 | -88.2% | 0.00% | -95.6% |
| Q3 2016 | $1,466,000 | -83.1% | 362,828 | -33.9% | 0.04% | -78.0% |
| Q4 2015 | $8,695,000 | +697.0% | 548,708 | +430.1% | 0.20% | +502.9% |
| Q3 2015 | $1,091,000 | -24.0% | 103,508 | +27.4% | 0.03% | -19.0% |
| Q1 2014 | $1,435,000 | +48.2% | 81,223 | +103.1% | 0.04% | +75.0% |
| Q4 2013 | $968,000 | -81.9% | 39,996 | -88.3% | 0.02% | -83.4% |
| Q2 2013 | $5,350,000 | – | 342,739 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |